US equities
|
META
$630.56
▲+0.00%
MU
$903.70
▲+0.00%
TSLA
$391.62
▲+0.00%
NVDA
$216.00
▲+0.00%
SPCX
$146.90
▲+0.00%
SNDK
$1,255.58
▲+0.00%
SOFI
$14.46
▲+0.00%
INTC
$90.47
▲+0.00%
META
$630.56
▲+0.00%
MU
$903.70
▲+0.00%
TSLA
$391.62
▲+0.00%
NVDA
$216.00
▲+0.00%
SPCX
$146.90
▲+0.00%
SNDK
$1,255.58
▲+0.00%
SOFI
$14.46
▲+0.00%
INTC
$90.47
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Sue Dillon
Recent news which mentions Sue Dillon
Aro Biotherapeutics identifies a lead target for its centyrins technology
May 11, 2022
Tags
Insurance
Sue Dillon
Biotech
From
Business Journals